Press Release: Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Dow JonesJul 18 16:05 ET

Ocular Therapeutix (OCUL) Gets a Buy From Piper Sandler

TipRanksJul 17 12:11 ET

Investors Await Earnings Reports, Tech Stocks Take Hit as US Futures Fall Sharply Pre-Bell

MT NewswiresJul 17 08:08 ET

Institutional Investors Have a Lot Riding on Ocular Therapeutix, Inc. (NASDAQ:OCUL) With 64% Ownership

Simply Wall StJul 14 10:01 ET

The One-year Returns Have Been Notable for Ocular Therapeutix (NASDAQ:OCUL) Shareholders Despite Underlying Losses Increasing

Yahoo FinanceJul 12 08:07 ET

Piper Sandler Sticks to Their Buy Rating for Ocular Therapeutix (OCUL)

TipRanksJul 12 06:37 ET